Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

192.29 +2.34 (+1.23%)
Streaming Delayed Price Updated: 1:45 PM EST, Feb 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,983,176
Open 190.52
Bid (Size) 192.28 (2)
Ask (Size) 192.34 (1)
Prev. Close 189.95
Today's Range 189.92 - 193.38
52wk Range 153.58 - 207.32
Shares Outstanding N/A
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” 
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Monday. 
Via Chartmill

Performance

YTD
+7.16%
+7.16%
1 Month
+6.77%
+6.77%
3 Month
-4.66%
-4.66%
6 Month
+3.54%
+3.54%
1 Year
+12.28%
+12.28%

More News

Read More
Can Biotech Stocks Survive The Precarious Macro?
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Top S&P500 movers in Monday's session
Via Chartmill
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
Why AbbVie Stock Is Jumping Today
Via The Motley Fool
Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
What You Missed On Friday
Via Talk Markets
Topics Stocks / Equities
U.S. Equity Rally Reverses As White House Confirms Imminent Tariffs, Shifting Focus To Fed Policy
Via Talk Markets
Topics Commodities Economy Futures
Exposures Interest Rates Tariff
Small- To Mid-Cap Biotech Trades Poised For Gains
Via Talk Markets
Topics ETFs Stocks / Equities
Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
Via The Motley Fool
What's going on in today's session: S&P500 movers
Via Chartmill
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Via StockStory
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Via Benzinga
AbbVie (ABBV) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Top S&P500 movers in Friday's session
Via Chartmill
Tech Stocks Rally, S&P 500 Flirts With Records, Gold Extends All-Time Highs: What's Driving Markets Friday?
Via Benzinga
Topics Stocks
Exposures US Equities
AbbVie Investors Trigger Trend-Following Signal: Time to Load Up
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
AbbVie Stock Nears 3-Month High on Q4 Beat As Immunology Growth Eases Humira Slump: Retail Mood Brightens
Via Stocktwits
Charter Communications Posts Upbeat Earnings, Joins Atlassian, SkyWest, Eastman Chemical, AbbVie And Other Big Stocks Moving Higher On Friday
Via Benzinga
AbbVie Jumps After Q4 Earnings Beat, Skyrizi And Rinvoq Boom Offsets Humira Decline
Via Benzinga
Topics Earnings
Exposures Financial
5 Top Stocks to Buy in February 2025
Via The Motley Fool
Friday's pre-market session: top gainers and losers in the S&P500 index
Via Chartmill
AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate
Via Investor's Business Daily
US Stock Futures Climb After Apple Beats Q4 Expectations: Expert Says Tech Stocks Hold Above Key Level Despite DeepSeek Impact
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.